Discover
HCWB
HCW Biologics Inc.
1.87
2 x 1.48
2 x 2.71
bid
ask
-
0.08
4.10%
2 @ 07:30 PM
1.87 +0.00 (0.00%)
| Ytd | -67.92% | |
| 1y | -93.14% |
1.87
day range
2.15
1.61
52 week range
29.28
| Open | 2.00 | Prev Close | 1.95 | Low | 1.87 | High | 2.15 | Mkt Cap | 3.43M |
| Vol | 87.62K | Avg Vol | 169.74K | EPS | -16.62 | P/E | N/A | Forward P/E | -0.73 |
| Beta | 0.84 | Short Ratio | 0.28 | Inst. Own | 3.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 3.05 | 200-d Avg | 5.34 | 1yr Est | 3.00 |
| Income Statement | |||
| Total Revenue | 135.57K | ||
| Revenues (USD) | 135.57K | ||
| Cost of Revenue | 229.46K | ||
| Gross Profit | -93.89K | ||
| Operating Expenses | 3.07M | ||
| Research and Development Expense | 1.20M | ||
| Selling, General and Administrative Expense | 1.87M | ||
| Operating Income | -3.17M | ||
| Interest Expense | 100.54K | ||
| Net Income | -5.22M | ||
| Net Income Common Stock | -15.37M | ||
| Net Income Common Stock (USD) | -15.37M | ||
| Consolidated Income | -5.22M | ||
| Earnings per Basic Share | -11.58 | ||
| Earnings per Basic Share (USD) | -11.58 | ||
| Earnings per Diluted Share | -11.58 | ||
| Earning Before Interest & Taxes (EBIT) | -5.12M | ||
| Earning Before Interest & Taxes (USD) | -5.12M | ||
| Preferred Dividends Income Statement Impact | 10.15M | ||
| Weighted Average Shares | 1.33M | ||
| Weighted Average Shares Diluted | 1.33M | ||
| Balance Sheet | |||
| Cash and Equivalents | 741.32K | ||
| Cash and Equivalents (USD) | 741.32K | ||
| Investments | 4.85M | ||
| Investments Non-Current | 4.85M | ||
| Trade and Non-Trade Receivables | 18.45K | ||
| Current Assets | 1.14M | ||
| Property, Plant & Equipment Net | 20.75M | ||
| Total Assets | 26.77M | ||
| Debt Current | 6.56M | ||
| Total Debt | 6.56M | ||
| Current Liabilities | 18.65M | ||
| Total Liabilities | 19.34M | ||
| Accumulated Retained Earnings (Deficit) | -110.26M | ||
| Shareholders Equity | 7.43M | ||
| Shareholders Equity (USD) | 7.43M | ||
| Assets Non-Current | 25.63M | ||
| Total Debt (USD) | 6.56M | ||
| Deferred Revenue | 348.27K | ||
| Liabilities Non-Current | 692.53K | ||
| Trade and Non-Trade Payables | 10.61M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 127.10K | ||
| Net Cash Flow from Financing | 3.48M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -487.55K | ||
| Issuance (Purchase) of Equity Shares | 3.51M | ||
| Issuance (Repayment) of Debt Securities | -32.84K | ||
| Net Cash Flow from Operations | -3.97M | ||
| Share Based Compensation | 1.22K | ||